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Summary 39 
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory 40 
infections (ALRI) in children. This is the first study using original source high-quality 41 
surveillance data to establish a global, robust and homogeneous report on global 42 
country-specific RSV seasonality. 43 
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ABSTRACT 75 
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory 76 
infections (ALRI) in children. By the age of 1 year, 60–70% of children have been infected 77 
by RSV. In addition, early-life RSV infection is associated with the development of 78 
recurrent wheezing and asthma in infancy and childhood. The need for precise 79 
epidemiologic data regarding RSV as a worldwide pathogen has been growing steadily 80 
as novel RSV therapeutics are reaching the final stages of development. To optimize the 81 
prevention, diagnosis and treatment of RSV infection in a timely manner, knowledge 82 
about the differences in the timing of the RSV epidemics worldwide is needed. Until 83 
recently, only certain countries have been recording RSV incidence through their own 84 
surveillance systems. This analysis is based on national RSV surveillance reports and 85 
medical databases from 27 countries worldwide. Other analyses are based on literature 86 
reviews of individual reports obtained from medical databases, failing to provide global 87 
country seasonality patterns. This is the first study using original source high-quality 88 
surveillance data to establish a global, robust and homogeneous report on global 89 
country-specific RSV seasonality.  90 
 91 
Keywords: RSV; RSV Seasonality; RSV Epidemiology; RSV Epidemics; Acute Lower 92 
Respiratory Infections; Respiratory Infections; RSV Surveillance; Surveillance. 93 
 94 
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BACKGROUND 96 
 97 
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory 98 
infections (ALRI) in children. By the age of 1 year, 60–70% of children have been infected 99 
by RSV (2–3% of whom are hospitalized), and almost all children have been infected by 100 
2 years of age [1]. This virus is estimated to cause approximately 33.8 million new 101 
episodes of ALRI annually in children <5 years of age worldwide, resulting in 3.2 million 102 
hospital admissions and 59,600 in-hospital deaths in children <5 years in 2015 [2]. In 103 
addition early-life RSV infection is associated with the development of recurrent 104 
wheezing and asthma in infancy and childhood [3] 105 
The need for precise epidemiologic data regarding RSV as a worldwide pathogen has 106 
been growing steadily as novel vaccines and molecules for the prevention and treatment 107 
of RSV infections are reaching the final stages of development [4]. In order to establish 108 
timely counter-measures to control the pathogen, information about the different 109 
epidemic waves of the virus is needed [4]. Many western countries have included 110 
detection of RSV as part of their influenza surveillance system, especially since it was 111 
noted that its circulation generally predates that of the influenza virus by six to eight 112 
weeks. Nevertheless, many countries have not implemented a routine surveillance 113 
system for RSV, or they have done so only in certain regions, or even restricted to 114 
specific medical facilities. The aim of this report is to provide an overview of RSV 115 
seasonality throughout 27 countries across the world. 116 
 117 
 118 
 119 
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METHODS 120 
We surveyed 27 countries distributed among nine predefined geographical areas for 121 
epidemiological data (Figure 1). 122 
 123 
Figure 1 124 
 125 
Selection strategy 126 
Selection of the regions studied was done through a two-searches approximation 127 
conducted between June 2016 to September 2017. A first general search was conducted 128 
in Google to detect countries with official surveillance programs producing accessible 129 
reports containing information on RSV seasonality. Terms included were “RSV” or 130 
“Respiratory syncytial virus” or “Influenza” plus “Surveillance”. A total of 19 countries 131 
with  were selected. Most surveillance systems had RSV-specific data available from 132 
laboratory detections, but for France we used syndromic “bronchiolitis” data. To 133 
complement and compare the information obtained from the official reports and to 134 
increase the information gathered in poorly covered areas, a literature review was 135 
performed  in PubMed of articles published between 1990 and 2017. Keywords included 136 
‘respiratory virus’, OR ‘respiratory syncytial virus,’ OR ‘RSV,’ in combination with 137 
‘seasonality’ OR ‘surveillance’. Only studies reflecting specific information on RSV 138 
seasonality (i.e. start, end, peak or duration of the RSV season) were extracted. A total 139 
of 8 new countries were added to the initial survey to increase the total number of 140 
countries studied to the final figure of 27.  Only records written in English, Spanish, 141 
German, French and Portuguese were included in this study. 142 
 143 
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Information retrieved 144 
Variables recovered from the different reports were as follow: Start and end of the RSV 145 
season (in epidemiological week or month if the specific week was not available), peak 146 
of RSV activity (in epidemiological week or month if the specific week was not available), 147 
duration of the seasons, presence of official RSV surveillance program, period studied, 148 
region variability and usage of laboratory detection. Data for each country were 149 
collected by two independent investigators from the ReSVinet (Respiratory Syncytial 150 
Virus Network) / GENVIP (Genetics, Vaccines, Infectious Diseases and Pediatrics) 151 
research groups. 152 
We relied on data provided by official national reports to establish the start and end of 153 
the RSV season, whenever available. In Europe, the first reports with official data about 154 
RSV detection are available as early as 1995 for Finland, 1996 for Germany and 1998 for 155 
Belgium, and as late as the end of the 2000s for as Spain and UK. In South and Central 156 
America, the earliest reports are found in 2009 for Brazil and Argentina. North America 157 
RSV official seasonality reports date as early as 1983. With the exception of New 158 
Zealand, that presents information regarding RSV since 1997, the rest of the countries 159 
studied have accessible data on RSV surveillance starting from the late 2000s. We 160 
recovered information from official surveillance organization reports from 2010 161 
onwards whenever possible.  162 
In countries with no official sources on RSV epidemiology and disease burden, 163 
information was systematically extracted from the best reliable medical source at our 164 
disposal. Initially, WHO and CDC reports for each of the countries were reviewed, then 165 
local and multicenter publications assessing several consecutive RSV seasons were also 166 
reviewed, and finally a review of published articles documenting RSV burden limited to 167 
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a local area or a group of hospitals were used, if no better sources were available. For 168 
those countries with no precise information regarding exact timing and duration of RSV 169 
season, the onset of RSV season was defined as the first two consecutive weeks when 170 
10% or higher of the total tested samples for respiratory pathogens were positive for 171 
RSV. The end of the RSV season was defined similarly when the proportion of positive 172 
RSV tests fell below 10% for two consecutive weeks. 173 
 174 
RESULTS 175 
Although there were major differences among the 27 countries studied, seasonal RSV 176 
epidemics within each individual country were consistent over time. We found that even 177 
when global trends were documented and usually repeated over seasons, some 178 
variations between different years were observed. Even when most countries included 179 
(19 out of 27) had official surveillance systems, information devoted to RSV was usually 180 
scarce and embedded within influenza surveillance reports (Figure 2). Almost every 181 
sentinel program detected RSV through laboratory methods (excluding France), but 182 
almost no information regarding the specifics of the microbiological test used was 183 
available in the majority of the reports.   184 
Table 1 and Figure 2 summarize the RSV seasonality data per country, and a detailed 185 
version of Europe is presented in Figure 3. 186 
 187 
Table 1 188 
 189 
Figure 2 190 
 191 
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Figure 3 192 
 193 
Globally, RSV epidemics started in the South moving to the North. We found that the 194 
RSV wave started in most countries situated in the Southern Hemisphere between 195 
March and June, and in the Northern Hemisphere between September and December 196 
[5–7]. Decrease in RSV activity was observed from August to October in the Southern 197 
Hemisphere and from February to May in the Northern Hemisphere [5-7]. Regarding 198 
duration, most countries in both hemispheres had seasons that occupied from 5 to 6 199 
months in total. While this was the general rule, shorter seasons were seen in Spain 200 
(from 3 to 5 months) [8], UK (from 3 to 4 months) [9] and Israel (4 months) [10] in the 201 
northern hemisphere whilst in the southern hemisphere RSV activity in Australia [11] 202 
mainly lasts approximately 4 months long. An exception to this patterns was seen in 203 
countries were humid or rainy seasons was seen,  particularly those near the equatorial 204 
area like Mozambique [12,13] or Malaysia [14], were RSV tended to linger longer, up to 205 
10 months duration.  206 
The seasonality was fairly consistent within most regions, although we observed 207 
variations from year to year. These variations were independent of the hemisphere and 208 
the majority remained between 1 to 3 weeks difference from season to season in the 209 
start, end and/or peak of RSV activity. Most countries showed major variations of 1 210 
month least once during the studied periods. Curiously, these major variations were less 211 
appreciated in the regions were no surveillance system was stablished (probably related 212 
to the scarce sources of information found). Despite the straight forward trends 213 
described, there were some countries that presented irregular patterns. In Germany 214 
[15], two differential patterns of RSV seasonality have been detected: an early season 215 
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starting in October-November and finishing in March-April and a late season starting in 216 
December and finishing in May, having both seasons a similar duration. RSV infections 217 
in Finland, according to the data gathered from the literature review, follow a two-year 218 
cycle [16,17]. A small epidemic in spring of every odd-numbered year, is followed by a 219 
major epidemic that starts in November-December and extends to the next spring. 220 
Seasonality also follows a distinctive pattern in Mexico [18]. A two-season year is 221 
followed by a milder year were the outbreak starts in spring, maintaining activity almost 222 
all year round with no clear peaks. Intra-country differences in seasonality were noted, 223 
especially in countries with large territories and different regional climatic regions, such 224 
as Brazil [19], the USA [20] or Australia [21-23]. Additional details and references on 225 
seasonality of RSV by region is available in the supplemental material. 226 
 227 
DISCUSSION 228 
To our knowledge, this is the first study using original source high-quality data relying 229 
predominantly on the official information gathered by the different surveillance 230 
networks to establish a global report on country-specific RSV seasonality that allowed 231 
us to observe the typical worldwide distribution of RSV seasonality at a glance. We have 232 
included a wide selection of information retrieved not only from research studies, but 233 
also and more importantly, from the actual surveillance systems in the different 234 
countries. This method allowed us to obtain better distribution and homogeneity of the 235 
information acquired than did studies based exclusively on literature reviews. Those 236 
earlier studies usually recorded information in hospital settings, reporting data from few 237 
regions or centres, thus failing to establish global country seasonality patterns. 238 
Furthermore, we could not find in the literature any other review that reflects the 239 
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specific ranges in which seasons and RSV peaks of activity vary during the periods 240 
studied. Many other original papers are based on regional or single country data, and 241 
they have been useful for analysing the circulation of RSV in their respective regions 242 
[6,12-14,16-17,19,22-24,27-48].  243 
The first global RSV seasonality study found in the literature was conducted in 2002 by 244 
Stensballe et al. [5]. The authors reported different patterns for the Northern and 245 
Southern hemispheres and the equatorial region in a city-based format, relying on 246 
information provided by medical databases. Haynes et al. [6] worked in conjunction with 247 
the Centers for Disease Control and Prevention (CDC) Global Disease Detection Centers 248 
to investigate different trends in low- and middle-income countries. They analysed the 249 
data in conjunction with the climate patterns. The largest study in the literature was 250 
carried out by Bloom-Feshbach et al. [7] where information from 137 global locations 251 
based on a literature review, electronic sources and the WHO surveillance system FluNet 252 
was reported. Their study showed seasonal patterns of RSV similar to the present study, 253 
with temperate locations of the Northern and Southern Hemispheres characterized by 254 
focused peaks of activity during their respective winters, and a wide range of variability 255 
in the timing and duration of epidemics in the tropics.   256 
In regard to weather conditions, the general rule in temperate climate regions such as 257 
those of Europe or North America, is that RSV activity follows the decrease in 258 
temperature. Exceptions were observed  in equatorial countries and tropical areas with 259 
high humidity, such as the Philippines or Mozambique, where viral circulation is seen 260 
primarily during the rainy season, although showing residual activity throughout the 261 
year [5–7]. 262 
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This study is meant to serve as a general guide for RSV seasonality, not only to provide 263 
general knowledge about the epidemiology of the virus but also to serve as a basis for 264 
actual preventive and therapeutic strategies against RSV using established prophylaxis 265 
measures and/or those about to be released to the market. Even though we have 266 
highlighted the consistency between seasons and  we expect this information to be very 267 
useful, it should be considered as a complement for the actual information gathered in 268 
real time by the current surveillance systems. Major variations of a month or more that 269 
could make a preventive measure useless do occur occasionaly. Therefore, we propose 270 
that the best approach to predict RSV outbreaks is to construct a robust, homogeneous, 271 
active and global surveillance program with real-time data to help predict the 272 
epidemiologic waves in a timely fashion. A number of countries have been recording 273 
RSV cases through their own surveillance systems for some years now. These countries, 274 
however, are part of a minority, and most of them only include RSV surveillance as a 275 
secondary detection along with other surveillance campaigns (i.e. influenza virus and 276 
bronchiolitis surveillance), with scarce information regarding RSV. In areas without 277 
official surveillance systems, one has to rely on single or multicenter studies done by 278 
various research groups.  279 
To this respect, the WHO through the Global Influenza Surveillance and Response 280 
System (GISRS) is in process of implementing a pilot of RSV surveillance based on the 281 
influenza surveillance platform, with 14 countries selected covering for each of the WHO 282 
regions [49]. 283 
Our approach also allowed us to study the seasonality of RSV for longer periods of time, 284 
as RSV surveillance systems have been in operation in some of the areas for many years.  285 
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Prevention of the RSV infection  could not only protect children from the acute effects 286 
of the disease but also improve long-term respiratory morbidity such as recurrent 287 
wheezing and asthma [50].  288 
A limitation of our approach is that information collected from middle- and low-income 289 
countries is scarce as most of these regions lack RSV surveillance networks. In particular, 290 
we acknowledge that certain regions such as Africa are underrepresented in our 291 
analysis. As the main approach of this review is describing the seasonality of RSV, we did 292 
not analyze further epidemiological data like transmission patterns or activity of other 293 
viral pathogens. Although the effect of climate in the different RSV seasonality patterns 294 
was observed in the study for different countries, we did not conduct a deep analysis of 295 
this fact, as actual meteorological data was not extracted during the review. It will be 296 
interesting to further develop this idea in following analyses. Although most of the 297 
surveillance programs do perform sample testing in subjects with symptoms of 298 
respiratory infection, those surveillance networks were influenza like illness is the driver 299 
of sampling performance could underestimate RSV epidemic unless Influenza and RSV 300 
overlap. Finally, circulation of the different RSV subtypes was not further analyzed, as 301 
almost no surveillance network differentiates between the different genotypes. We 302 
decided not to include information in this respect as the literature is based on small 303 
sample studies carried out for short periods, preventing a global review of the subject.   304 
 305 
In summary, this report provides information that may allow prediction of the beginning 306 
of outbreaks of RSV across the world. Even when local epidemic waves are consistent 307 
between different years, minor changes between seasons are present from year to year. 308 
This variability could turn a prophylactic measure into a useless endeavor if, for example, 309 
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vaccination campaigns against RSV begin when the outbreak has already started. 310 
Therefore, as the data has shown, future seasonal RSV vaccinations campaigns should 311 
be organized after the different patterns repeated in each region were the program is 312 
planned to be implemented . Although a general dissemination pattern exists for RSV, 313 
the described variations from season to season justify introduction of new well-314 
organized supranational and country- or region-based RSV-specific surveillance tools to 315 
predict this variations, as it has been done for Influenza virus infections in the past.. The 316 
experience with the Influenza virus model has taught us that the effectiveness of efforts 317 
directed towards preventive and prophylactic measures would be increased if the 318 
seasonal and epidemiological characteristics of the virus waves could be better 319 
predicted.  As novel RSV therapeutics are expected to soon become available [20], local 320 
seasonality data will allow optimizing the prevention, diagnosis and treatment of RSV 321 
infections.  322 
323 
15 
 
REFERENCES 324 
 325 
1. Stein RT, Bont LJ, Zar H, et al. Respiratory syncytial virus hospitalization and mortality: 326 
Systematic review and meta‐analysis. Pediatr Pulmonol. 2017; 52(4):556–569.  327 
2. Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden 328 
estimates of acute lower respiratory infections due to respiratory syncytial virus in young 329 
children in 2015: a systematic review and modelling study. The Lancet. 2017; 330 
390(10098):946–958.  331 
3. Fauroux B, Simões EAF, Checchia PA, et al. The Burden and Long-term Respiratory 332 
Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect 333 
Dis Ther. 2017; 6(2):173–197.  334 
4. Global RSV surveillance. Releve Epidemiol Hebd. 2016; 91(44):523–524.  335 
5. Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the 336 
ups and downs of a seasonal virus. Pediatr Infect Dis J. 2003; 22(2 Suppl):S21-32.  337 
6. Haynes AK, Manangan AP, Iwane MK, et al. Respiratory syncytial virus circulation in seven 338 
countries with Global Disease Detection Regional Centers. J Infect Dis. 2013; 208 Suppl 339 
3:S246-254.  340 
7. Bloom-Feshbach K, Alonso WJ, Charu V, et al. Latitudinal variations in seasonal activity of 341 
influenza and respiratory syncytial virus (RSV): a global comparative review. PloS One. 342 
2013; 8(2):e54445.  343 
8. Informe de Vigilancia de la Gripe en España. Available at: 344 
http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-345 
alertas/fd-enfermedades/gripe.shtml. Accessed 6 Sep 2017. 346 
16 
 
9. Annual flu reports - GOV.UK. Available at: 347 
https://www.gov.uk/government/statistics/annual-flu-reports. Accessed 6 Sep 2017. 348 
10. Surveillance of Influenza Like Ilness in Israel. Available at: 349 
https://www.health.gov.il/English/MinistryUnits/ICDC/Infectious_diseases/Flu/Pages/F350 
WR.aspx. Accessed 6 Sep 2017. 351 
11. Australian Sentinel Practices Research Network, 2016. Australian Government 352 
Department of Health. Available at: 353 
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi4101o.htm. 354 
Accessed 6 Sep 2017. 355 
12. Robertson SE, Roca A, Alonso P, et al. Respiratory syncytial virus infection: denominator-356 
based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health 357 
Organ. 2004; 82(12):914–922.  358 
13. Loscertales MP, Roca A, Ventura PJ, et al. Epidemiology and clinical presentation of 359 
respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatr 360 
Infect Dis J. 2002; 21(2):148–155.  361 
14. Khor C-S, Sam I-C, Hooi P-S, Quek K-F, Chan Y-F. Epidemiology and seasonality of 362 
respiratory viral infections in hospitalized children in Kuala Lumpur, Malaysia: a 363 
retrospective study of 27 years. BMC Pediatr. 2012; 12:32.  364 
15. RKI (Arbeitsgemeinschaft Influenza): Saisonberichte. Available at: 365 
https://influenza.rki.de/Saisonbericht.aspx. Accessed 6 Sep 2017. 366 
16. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with 367 
alternating prevalence of groups A and B. J Infect Dis. 1991; 163(3):464–469.  368 
17. Gunell M, Antikainen P, Porjo N, et al. Comprehensive real-time epidemiological data 369 
from respiratory infections in Finland between 2010 and 2014 obtained from an 370 
17 
 
automated and multianalyte mariPOC® respiratory pathogen test. Eur J Clin Microbiol 371 
Infect Dis Off Publ Eur Soc Clin Microbiol. 2016; 35(3):405–413.  372 
18. Dirección general de epidemiología. Informe semanal de vigilancia epidemiológica: 373 
Influenza 2015. Available at: 374 
http://www.epidemiologia.salud.gob.mx/informes/informesh/2015/docto%20s/influenz375 
a/INFLUENZA_2015_SE39.pdf. Accessed 6 Sep 2017. 376 
19. Freitas ARR, Donalisio MR. Respiratory syncytial virus seasonality in Brazil: implications 377 
for the immunisation policy for at-risk populations. Mem Inst Oswaldo Cruz. 2016; 378 
111(5):294–301.  379 
20. NREVSS | RSV Surveillance Data | CDC [Internet]. Available at: 380 
https://www.cdc.gov/surveillance/nrevss/rsv/index.html. Accessed 6 Sep 2017. 381 
21. Australian Sentinel Practices Research Network, 2016. Australian Government 382 
Department of Health. Available at: 383 
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi4101o.htm. 384 
Accessed 6 Sep 2017. 385 
22. Hogan AB, Anderssen RS, Davis S, et al. Time series analysis of RSV and bronchiolitis 386 
seasonality in temperate and tropical Western Australia. Epidemics. 2016; 16:49–55.  387 
23. Paynter S, Ware RS, Sly PD, Weinstein P, Williams G. Respiratory syncytial virus 388 
seasonality in tropical Australia. Aust N Z J Public Health. 2015; 39(1):8–10.  389 
24. Ducoffre G, Quoilin S, Wuillaume F. Surveillance of influenza A and respiratory syncytial 390 
virus by the Belgian Sentinel Laboratory Network. Arch Public Health. 2010; 68(2):83–84.  391 
18 
 
25. Houspie L, Lemey P, Keyaerts E, et al. Circulation of HRSV in Belgium: from multiple 392 
genotype circulation to prolonged circulation of predominant genotypes. PloS One. 2013; 393 
8(4):e60416. 394 
26. Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M. Subgroup Prevalence 395 
and Genotype Circulation Patterns of Human Respiratory Syncytial Virus in Belgium 396 
during Ten Successive Epidemic Seasons. J Clin Microbiol. 2007; 45(9):3022–3030.  397 
27. Raes M, Cox B, Strens D, Nawrot TS. Seasonality of Respiratory Syncytial Virus in Belgium. 398 
Am J Perinatol. 2016; 33(S 01):A024.  399 
28. Lanari M, Giovannini M, Giuffré L, et al. Prevalence of respiratory syncytial virus infection 400 
in Italian infants hospitalized for acute lower respiratory tract infections, and association 401 
between respiratory syncytial virus infection risk factors and disease severity. Pediatr 402 
Pulmonol. 2002; 33(6):458–465.  403 
29. Cangiano G, Nenna R, Frassanito A, et al. Bronchiolitis: Analysis of 10 consecutive 404 
epidemic seasons. Pediatr Pulmonol. 2016; 51(12):1330–1335.  405 
30. Medici MC, Arcangeletti MC, Rossi GA, et al. Four year incidence of respiratory syncytial 406 
virus infection in infants and young children referred to emergency departments for 407 
lower respiratory tract diseases in Italy: the “Osservatorio VRS” Study (2000-2004). New 408 
Microbiol. 2006; 29(1):35–43.  409 
31. Jiménez-Jorge S, Delgado-Sanz C, Mateo S de, et al. [Monitoring respiratory syncytial 410 
virus through the Spanish influenza surveillance system, 2006-2014]. Enferm Infecc 411 
Microbiol Clin. 2016; 34(2):117–120.  412 
32. Cebey-López M, Herberg J, Pardo-Seco J, et al. Viral Co-Infections in Pediatric Patients 413 
Hospitalized with Lower Tract Acute Respiratory Infections. PloS One. 2015; 414 
10(9):e0136526.  415 
19 
 
33. Sirimi N, Miligkos M, Koutouzi F, Petridou E, Siahanidou T, Michos A. Respiratory 416 
syncytial virus activity and climate parameters during a 12-year period. J Med Virol. 2016; 417 
88(6):931–937.  418 
34. Tsolia MN, Kafetzis D, Danelatou K, et al. Epidemiology of respiratory syncytial virus 419 
bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol. 2003; 18(1):55–61.  420 
35. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with 421 
increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002; 422 
165(9):1285–1289.  423 
36. Prel J-B du, Puppe W, Gröndahl B, et al. Are meteorological parameters associated with 424 
acute respiratory tract infections? Clin Infect Dis Off Publ Infect Dis Soc Am. 2009; 425 
49(6):861–868.  426 
37. Terletskaia-Ladwig E, Enders G, Schalasta G, Enders M. Defining the timing of respiratory 427 
syncytial virus (RSV) outbreaks: an epidemiological study. BMC Infect Dis. 2005; 5:20.  428 
38. Visseaux B, Collin G, Ichou H, et al. Usefulness of multiplex PCR methods and respiratory 429 
viruses’ distribution in children below 15 years old according to age, seasons and clinical 430 
units in France: A 3 years retrospective study. PloS One. 2017; 12(2):e0172809.  431 
39. Gamiño‐Arroyo AE, Moreno‐Espinosa S, Llamosas‐Gallardo B, et al. Epidemiology and 432 
clinical characteristics of respiratory syncytial virus infections among children and adults 433 
in Mexico. Influenza Other Respir Viruses. 2017; 11(1):48–56.  434 
40. Ferrero F, Torres F, Abrutzky R, et al. Seasonality of respiratory syncytial virus in Buenos 435 
Aires. Relationship with global climate change. Arch Argent Pediatr. 2016; 114(1):52–55.  436 
41. Marcone DN, Ellis A, Videla C, et al. Viral etiology of acute respiratory infections in 437 
hospitalized and outpatient children in Buenos Aires, Argentina. Pediatr Infect Dis J. 438 
2013; 32(3):e105-110.  439 
20 
 
42. Otomaru H, Kamigaki T, Tamaki R, et al. Influenza and other respiratory viruses detected 440 
by influenza-like illness surveillance in Leyte Island, the Philippines, 2010-2013. PloS One. 441 
2015; 10(4):e0123755.  442 
43. Suzuki A, Lupisan S, Furuse Y, et al. Respiratory viruses from hospitalized children with 443 
severe pneumonia in the Philippines. BMC Infect Dis. 2012; 12:267.  444 
44. Khor C-S, Sam I-C, Hooi P-S, Quek K-F, Chan Y-F. Epidemiology and seasonality of 445 
respiratory viral infections in hospitalized children in Kuala Lumpur, Malaysia: a 446 
retrospective study of 27 years. BMC Pediatr. 2012; 12:32.  447 
45. Siritantikorn S, Puthavathana P, Suwanjutha S, et al. Acute viral lower respiratory 448 
infections in children in a rural community in Thailand. J Med Assoc Thail Chotmaihet 449 
Thangphaet. 2002; 85 Suppl 4:S1167-1175.  450 
46. Park KH, Shin JH, Lee EH, et al. Seasonal Variations of Respiratory Syncytial Virus Infection 451 
among the Children under 60 Months of Age with Lower Respiratory Tract Infections in 452 
the Capital Area, the Republic of Korea, 2008-2011. J Korean Soc Neonatol. 2012; 453 
19(4):195.  454 
47. Zhang Y, Yuan L, Zhang Y, Zhang X, Zheng M, Kyaw MH. Burden of respiratory syncytial 455 
virus infections in China: Systematic review and meta-analysis. J Glob Health. 2015; 456 
5(2):020417.  457 
48. Wang H, Zheng Y, Deng J, et al. Prevalence of respiratory viruses among children 458 
hospitalized from respiratory infections in Shenzhen, China. Virol J. 2016; 13:39.   459 
49. Mazur NI, Martinón-Torres F, Baraldi E, et al. Lower respiratory tract infection caused by 460 
respiratory syncytial virus: current management and new therapeutics. Lancet Respir 461 
Med. 2015; 3(11):888–900.   462 
21 
 
WHO Technical Meeting on Piloting RSV Surveillance based on the Global Influenza 463 
Surveillance and Response System 28-30 June 2016. Available at: 464 
http://apps.who.int/iris/bitstream/10665/252617/1/WHO-OHE-PED-GIP-2016.6-465 
eng.pdf?ua=1. Accessed 6 Sep 2017. 466 
